We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. LNZ100, an aceclidine-based eye drop, demonstrated a ...
Please provide your email address to receive an email when new articles are posted on . Samples of Vizz are now going out to U.S. eye care providers, with commercial availability expected in the ...
Lenz Therapeutics has earned the FDA’s go-ahead for its aceclidine eye drop to crack the large presbyopia market, where past efforts by other drug developers have mostly been unsuccessful. The ...
Credit: Lenz Therapeutics. Aceclidine is a cholinergic muscarinic agonist that causes contraction of the iris sphincter muscle, thereby creating a pinhole effect that extends focus depth to improve ...
Broadcast Retirement Network's Jeffrey Snyder discusses treatments for presbyopia with the American Academy of Ophthalmology's Sidney Gicheru, MD. Current treatments include reading glasses, glasses ...
In a quiet but potentially transformative development for millions of Americans, the U.S. Food and Drug Administration (FDA) ...
(RTTNews) - Viatris Inc. (VTRS), Thursday announced positive top-line results from VEGA-3, evaluating MR-141 in patients with presbyopia, the progressive loss of the ability to focus on close objects.
Findings showed Brimochol PF significantly improved near vision compared with vehicle solution at all timepoints up to 8 hours (P .008). Topline data were announced from a phase 3 trial evaluating ...
A recent study reveals that eye drops containing pilocarpine and diclofenac can significantly improve near vision for ...